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Abstract
AIM: To determine whether ischemic preconditioning (IP)
affects the development of edematous cerulein-induced
pancreatitis and to assess the role of cyclooxygenase-1
(COX-1), COX-2, and heat shock protein 70 (HSP 70) in
this process.
METHODS: In male Wistar rats, IP was performed by
clamping of celiac artery (twice for 5 min at 5-min intervals).
Thirty minutes after IP or sham operation, acute pancreatitis
was induced by cerulein. Activity of COX-1 or COX-2 was
inhibited by resveratrol or rofecoxib, respectively (10 mg/kg).
RESULTS: IP significantly reduced pancreatic damage in
cerulein-induced pancreatitis as demonstrated by the
improvement of pancreas histology, reduction in serum
lipase and poly-C ribonuclease activity, and serum
concentration of pro-inflammatory interleukin (IL)-1β.
Also, IP attenuated the pancreatitis-evoked fall in
pancreatic blood flow and pancreatic DNA synthesis.
Serum level of anti-inflammatory IL-10 was not affected
by IP. Cerulein-induced pancreatitis and IP increased the
content of HSP 70 in the pancreas. Maximal increase in
HSP 70 was observed when IP was combined with
cerulein-induced pancreatitis. Inhibition of COXs, especially
COX-2, reduced the protective effect of IP in edematous
pancreatitis.
CONCLUSION: Our results indicate that IP reduces
pancreatic damage in cerulein-induced pancreatitis and
this effect, at least in part, depends on the activity of
COXs and pancreatic production of HSP 70.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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Various organs including the heart[1], brain[2], kidney[3], liver[4],
skeletal muscle[5], and stomach[6] respond to brief exposure
to ischemia with an increase in resistance to severe ischemia,
and this phenomenon is called ischemic preconditioning (IP).
Also, the protective effect of IP has been found in the pancreas
against ischemia/reperfusion-induced pancreatitis[7]. However,
no study so far has been undertaken to determine whether
IP is also able to prevent the acute pancreatic damage induced
by other primary non-vascular factors.
Cyclooxygenase (COX), the key enzyme for prostaglandin
synthesis, exists in two isoforms as COX-1 and COX-2[8].
COX-1 is constitutively expressed in most tissues and has
been suggested to mediate the synthesis of  prostaglandins
required for physiological functions and maintenance of organ
integrity. COX-2 is undetectable in most tissues in normal
condition, but is highly inducible by cytokines, mitogens, and
endotoxins, and is responsible for an increased production of
prostaglandins during inflammation[8]. However, it was reported
that both COXs contribute to gastric mucosal defense[9].
Inhibition of  COXs activity by nonselective nonsteroidal
anti-inflammatory drugs leads to induction of gastric ulcers
and delays the healing of gastric mucosa[10,11], while the
selective inhibition of  COX-2 delays gastric ulcer healing[12].
The role of  COX-2 in pancreatic pathology is unclear. Studies
performed by Song et al.[13], and Ethridge et al.[14], with mice
have shown that pharmacological inhibition of  COX-2 or
COX-2 gene disruption reduces the severity of  pancreatitis
and pancreatitis-associated lung injury. On the other hand,
our own study has shown that inhibition of  COX-2 abolishes
the protective effect of hepatocyte growth factor (HGF)
against cerulein-induced pancreatitis[15].
Heat shock proteins (HSPs) are cytoprotective molecules
that help to maintain the metabolic and structural integrity
of cells. HSPs are induced by a variety of stresses, including
heat, free radicals, and toxins[16]. In the pancreas, HSPs have
been shown to provide the protection against cerulein-[17,18]
and arginine-induced[19] acute pancreatitis. However, it is
not investigated whether IP interacts with HSPs and what
is the biological consequence of this potential interaction in
the development of cerulein-induced pancreatitis.
The present study was to determine the effect of  IP on
the development of acute cerulein-induced pancreatitis, to
evaluate the role of  COX-1 and COX-2 in pancreatic IP,




Studies were performed on male Wistar rats weighing
180-220 g and following the experimental protocol approved
by the Committee for Research and Animal Ethics of
Jagiellonian University. Rats were fasted for 18 h before
final experiment, but they had free access to drinking water.
Animals were housed in cages with wire mesh bottoms at
normal room temperature in 12-h light–dark cycle.
Experiments were carried out in the following
experimental groups (10 animals in each group); (1) sham-
operated control group; (2) IP group; (3) sham-operated
group treated with resveratrol (Cayman Chemicals, Ann Arbor,
MI, USA, 10 mg/kg, intragastrically (i.g.) 1 h before sham
operation); (4) sham-operated group treated with rofecoxib
(Vioxx, Merck Sharp & Dohme Idea Inc., Glattbrugg,
Switzerland, 10 mg/kg, i.g. 1 h before sham operation); (5)
sham-operated group with cerulein-induced pancreatitis; (6)
IP group with cerulein-induced pancreatitis; (7) sham-
operated group with cerulein-induced pancreatitis and treated
with resveratrol (10 mg/kg, i.g. 1 h before sham operation);
(8) cerulein-induced pancreatitis group treated with rofecoxib
(10 mg/kg, i.g. 1 h before sham operation); (9) IP group
with cerulein-induced pancreatitis and treated with resveratrol
(10 mg/kg, i.g. 1 h before IP); (10) IP group with cerulein-
induced pancreatitis and treated with rofecoxib (10 mg/kg,
i.g. 1 h before IP).
IP of  the pancreas was performed under ketamine
anesthesia (50 mg/kg i.p., Bioketan, Biowet, Gorzów Wlkp.,
Poland). After longitudinal laparotomy, the celiac artery was
clamped twice for 5 min at 5-min intervals. In sham-operated
rats, longitudinal laparotomy and mobilization of the
pancreas without the clamping of  any artery was performed.
Thirty minutes after IP or sham operation, acute
pancreatitis was induced by cerulein (Takus, Pharmacia &
Upjohn GmbH, Erlangen, Germany) i.p. five times at 1-h
intervals at a dose 10 μg/kg per injection. Animals without
induction of acute pancreatitis were treated with 0.9% NaCl
i.p. at the same time as cerulein.
Determination of pancreatic blood flow
After the last injection of cerulein or saline, animals were
anesthetized with ketamine and the abdomen was opened.
The pancreas was exposed for the measurement of pancreatic
blood flow by a laser Doppler flowmeter using PeriFlux
4001 Master monitor (Perimed AB, Järfälla, Sweden), as
described previously[20]. Pancreatic blood flow was measured
in five different portions of the pancreas. The area of laser
emission of the probe was about 1 mm2, while the depth
of measurement reached about 3 mm. Data were presented
as percent change from control value obtained in sham-
operated rats injected with saline.
Determination of serum lipase activity and serum interleukin-
1β and interleukin-10 concentration
Immediately after measurement of pancreatic blood flow,
the abdominal aorta was exposed and blood was taken for
determination of  serum lipase activity and serum interleukin-
1β (IL-1β) and IL-10 concentration. Serum lipase activity
was determined with a Kodak Ectachem DT II System
analyzer (Eastman Kodak Company, Rochester, NY, USA)
using Lipa DT slides (Vitros DT Chemistry System, Johnson
& Johnson Clinical Diagnostic, Inc., Rochester, NY, USA).
Serum lipase activity was expressed as units per liter. Serum
IL-1β and IL-10 concentrations were measured in duplicate,
using appropriate BioSource Cytoscreen rat kits based on a
solid phase sandwich ELISA (BioSource International,
Camarillo, CA, USA). Concentration of  IL was determined
from standard curves for recombinant IL-1β or IL-10,
respectively. Serum IL-1β or IL-10 concentration was
expressed as picogram per milliliter.
Determination of serum poly-C specific ribonuclease activity
Poly-C specific ribonuclease activity was determined using
Warsaw and Lee’s procedure[21], employing polycytydylic acid
(poly-C) as a ribonuclease substrate, as described previously
in detail[22]. Poly-C specific ribonuclease activity was expressed
in units per liter.
Protein extraction and analysis of pancreatic HSP 70
expression by Western blot analysis
Shock-frozen tissue from rat pancreas was homogenized in
a lysis buffer (100 mmol/L Tris-HCl, pH 7.4, 15% glycerol,
2 mmol/L EDTA, 2% sodium dodecyl sulfate (SDS),
100 mmol/L D,L-dithiothreitol) by the addition of 1:20
dilution of aprotinin and 1:50 dilution of 100 mmol/L
phenylmethylsulfonyl fluoride. Insoluble materials were
removed by centrifugation at 12 000 g for 15 min. Approximately
50 μg of the total protein extract was loaded on SDS-
polyacrylamide gels and run 40 mA, followed by transfer
on nitrocellulose membrane (Protran, Schleicher & Schuell,
Germany) by electroblotting. Bovine serum albumin (30 g/L,
Sigma-Aldrich, Germany) in Tris buffered saline (TBS)-
Tween-20 buffer (137 mmol NaCl, 20 mmol Tris-HCl, pH
7.4, 0.1% Tween-20) was used to block filters for at least 1 h
at room temperature. Specific primary antibody against HSP 70
(mouse monoclonal, 1:200 dilution; Stressgen Biotechnologies
Corp., Canada) or β-actin (mouse monoclonal, dilution 1:5 000;
Sigma-Aldrich, Germany) was added to the membrane,
followed by an anti-mouse-IgG or anti-mouse IgG horseradish
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peroxidase-conjugated secondary antibody (dilution 1:20 000;
Promega, WI, USA) dissolved in 1% non-fat milk in TBS-
Tween-20 buffer. Incubation of  primary antibody was
followed by washing thrice with TBS-Tween-20 buffer for
10 min. Incubation of the secondary antibody was followed
by five washes for 10 min. Immunocomplexes were detected
by the SuperSignal West Pico chemiluminescent kit (Pierce,
USA). Thereafter, the developed membrane was exposed to
an X-ray film (Kodak, Wiesbaden, Germany). Comparison
between different treatment groups was made by determining
the HSP 70/β-actin ratio of the immunoreactive area by
densitometry.
Determination of pancreatic DNA synthesis
The rate of DNA synthesis in samples of pancreatic tissue
was determined as described previously[23]. Briefly, the minced
pancreatic tissue was incubated at 37 ¡æ for 45 min in 2 mL
of medium containing 8 μCi/mL of [3H]thymidine ([6-3H]
thymidine, 20-30 Ci/mmol; Institute for Research, Production
and Application of Radioisotopes, Prague, Czech Republic).
The incorporation of [3H]thymidine into DNA was measured
by counting DNA containing solution in a liquid scintillation
system. DNA synthesis was expressed as [3H]thymidine
disintegrations per minute per microgram DNA (dpm/μg
DNA).
Histological examination
Samples of pancreatic tissue for histological examination
were fixed in 40 g/L formaldehyde, embedded in paraffin
and sections were sliced and stained with hematoxylin and
eosin. Slides were examined by two experienced pathologists
without the knowledge of the treatment given (four slides
per animal). The histological grading of edema was made using
our scale ranging from 0 to 3: 0 = no edema, 1 = interlobular
edema, 2 = interlobular and moderate intralobular edema,
and 3 = severe interlobular and intralobular edema.
Hemorrhage was graded: 0 = absent, 1 = 1-2 foci per slide,
2 = 3 to 5 foci per slide, 3 = more than 5 foci per slide.
Leukocyte infiltration was graded: 0 = absent, 1 = scare
perivascular infiltration, 2 = moderate perivascular and scare
diffuse infiltration, 3 = abundant diffuse infiltration. Acinar
necrosis was graded: 0 = absent, 1 = less than 15% of cells
involved, 2 = 15–35% of cells involved, 3 = more than
35% of cells involved. Grading of vacuolization was based
on the percentage of cells involved: 0 = absent, 1 = less
than 25%, 2 = 25-50% and 3 = more than 50%.
Statistical analysis
Results were expressed as mean±SE. Statistical analysis was
carried out by one-way analysis of variance followed by
Tukey’s multiple comparison test using GraphPadPrism
(GraphPad Software, San Diego, CA, USA). P<0.05 was
considered statistically significant.
RESULTS
Morphological features of pancreatic tissue
The pancreas of saline-treated sham-operated rats showed
no tissue alteration macroscopically and at light microscopic
level (Table 1). Exposure to IP combined with treatment
with saline caused the mild interlobular edema and minimal
vacuolization of acinar cells in cases 4 and 5, respectively.
Rest of the animals exposed to IP and treated with saline
did not show any histological alterations. Administration of
the COX-1 inhibitor - resveratrol - in saline-treated animals
did not affect pancreatic tissue morphology. Treatment with
combination of  the COX-2 inhibitor - rofecoxib - plus saline
had no effect on pancreatic histology or caused mild interlobular
edema. Administration of cerulein caused acute edematous
pancreatitis in all rats that were tested (Table 1). The pancreas
was grossly swollen and enlarged with a visible collection of
edematous fluid. At light microscopic level, moderate or
severe interlobular and intralobular edema was accompanied
with moderate perivascular and scare diffuse inflammatory
leukocyte infiltration. Vacuolization was observed in 25-50%
of acinar cells. Additionally, in few cases, one or two foci
of hemorrhages per slide were found. IP applied prior to
cerulein-induced pancreatitis reduced histological signs of
pancreatic damage such as pancreatic edema, inflammatory
infiltration, and vacuolization of acinar cells. Also, administration
of resveratrol or rofecoxib in combination with cerulein
slightly reduced the cerulein-evoked pancreatic damage. In
animals with IP applied prior to cerulein, inhibition of  COXs
abolished the beneficial effect of IP. This effect was especially
pronounced after administration of rofecoxib and pancreatic
damage was similar to that in animals treated with cerulein
alone (Table 1).
Effect of ischemic preconditioning, resveratrol, and rofecoxib
on serum lipase activity in rats without or with cerulein-induced
pancreatitis
In  sham-operated saline-treated  rats, serum lipase activity
reached 61.5±3.5 U/L (Figure 1A). IP, applied without
Table 1  Morphological features of pancreatic tissue of animals exposed to IP or sham-operated and treated with saline, resveratrol,
rofecoxib or cerulein alone or in combination
             Edema            Inflammatory infiltration     Vacuolization        Hemorrhages            Necrosis
Sham-operation+saline (control) 0 0 0 0 0
IP+saline                  0/1 0                  0/1 0 0
Resveratrol+sham operation+saline 0 0 0 0 0
Rofecoxib+sham operation+saline                  0/1 0 0 0 0
Sham-operation+cerulein                  2/3 2 2                  0/1 0
IP+cerulein 2 1 1 0 0
Resveratrol+sham operation+cerulein 2 1 2 0 0
Rofecoxib+sham operation+cerulein 2 1 2                  0/1 0
Resveratrol+IP+cerulein 2                  1/2 2 0 0
Rofecoxib+IP+cerulein                  2/3 2 2                  0/1 0
Numbers represent the predominant histological grading in each group.
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induction of acute pancreatitis, did not affect serum lipase
activity. Also, administration of  the COX-1 inhibitor -
resveratrol - or the COX-2 inhibitor - rofecoxib - had no
effect on serum lipase activity in rats treated with saline.
Administration of cerulein caused more than sevenfold increase
in serum lipase activity, when compared to that of saline-
treated control rats. IP markedly reduced the cerulein-
evoked increase in serum lipase activity by 37% (P<0.001).
Also, administration of resveratrol or rofecoxib reduced
serum lipase activity in animals with cerulein-induced
pancreatitis (P<0.01 or P<0.05, respectively). The effect of
these blockers of  COX on serum lipase activity was weaker
than the effect of IP, but was still statistically significant. In
contrast, administration of resveratrol or rofecoxib in
combination with IP significantly abolished the IP-evoked
reduction in serum lipase activity in animals with cerulein-
induced pancreatitis (P<0.001). However, serum lipase
activity in these animals was still lower than that in animals
with cerulein-induced pancreatitis and treated with resveratrol
or rofecoxib alone (Figure 1A).
Effect of ischemic preconditioning, resveratrol, and rofecoxib
on serum concentration of IL-1β and IL-10 in rats without or
with cerulein-induced pancreatitis
In control sham-operated rats treated with saline, the serum
IL-1β concentration was 69.9±3.1 pg/mL (Figure 1B). IP
or treatment with resveratrol or rofecoxib alone had no
effect on serum IL-1β in rats without induction of acute
pancreatitis. In sham-operated rats, cerulein caused more
than threefold increase in serum IL-1β concentration and
this increase was significantly diminished by IP (P<0.001).
Lower but still significant reduction of serum IL-1β was
also observed when administration of  cerulein was combined
with pretreatment with resveratrol (P<0.05). Administration
of rofecoxib alone tended to reduce the cerulein-evoked
increase in serum IL-1β concentration, but this effect was
not statistically significant. Pretreatment with resveratrol or
rofecoxib in animals with IP significantly reversed the
Figure 1  Effect of sham operation (SO), IP, resveratrol (RES) or rofecoxib
(ROF) applied alone or in combination on serum lipase activity (A), IL-1β (B),
poly-C ribonuclease (C), pancreatic DNA synthesis (D), and pancreatic blood
flow (E) in rats with or without cerulein-induced pancreatitis. aP<0.05 vs sham-
operated rats treated with cerulein alone, bP<0.001 vs sham-operated saline-
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IP-evoked decrease in serum IL-1β concentration in animals
with cerulein-induced pancreatitis (P<0.001, Figure 1B).
In control sham-operated rats treated with saline, the
serum IL-10 level reached 73.0±5.0 pg/mL (data not
shown). Neither IP nor resveratrol or rofecoxib or cerulein
applied alone or in their combination significantly affected
the serum IL-10 concentration.
Effect of ischemic preconditioning, resveratrol, and rofecoxib
on serum activity of poly-C ribonuclease in rats without or
with cerulein-induced pancreatitis
In saline-treated sham-operated control rats, serum poly-C
ribonuclease activity reached 125±25 U/L (Figure 1C). IP
or administration of resveratrol or rofecoxib did not affect
serum poly-C ribonuclease activity in animals without
induction of acute pancreatitis. Cerulein-induced pancreatitis
caused nearly 20-fold increase in serum poly-C ribonuclease
activity and this effect was strongly and significantly inhibited
by IP (P<0.001). Also administration of resveratrol or rofecoxib
reduced the cerulein-induced increase in serum activity of
poly-C ribonuclease, but the effect of these blockers of
COX was weaker than that of  IP (P<0.001). Combination
of resveratrol or rofecoxib plus IP decreased the serum
poly-C ribonuclease activity in cerulein-treated rats to the
similar values as administration of resveratrol or rofecoxib
in sham-operated rats with cerulein-induced pancreatitis
(Figure 1C).
Effect of ischemic preconditioning, resveratrol, and rofecoxib
on pancreatic DNA synthesis in rats without or with cerulein-
induced pancreatitis
In saline-treated sham-operated control rats, pancreatic DNA
synthesis reached 59.0±2.3 dpm/μg DNA (Figure 1D). IP
as well as administration of resveratrol or rofecoxib did
not affect pancreatic DNA synthesis in animals without
induction of acute pancreatitis. In animals with cerulein-induced
pancreatitis, pancreatic DNA synthesis was significantly reduced,
reaching 34.7±1.6 dpm/μg DNA (P<0.001). IP significantly
attenuated the pancreatitis-related reduction in pancreatic
DNA synthesis (P<0.001). Resveratrol or rofecoxib given
alone did not affect pancreatic DNA synthesis in animals
treated with cerulein. Pretreatment with resveratrol tended
to reduce the pancreatic DNA synthesis in animals treated
with a combination of IP plus cerulein, but this effect was
not statistically significant. In contrast, pretreatment with
rofecoxib significantly reduced the pancreatic DNA synthesis
in animals treated with IP plus cerulein (P<0.05).
Effect of ischemic preconditioning, resveratrol, and rofecoxib
on pancreatic blood flow in rats without or with cerulein-
induced pancreatitis
IP or treatment with resveratrol or rofecoxib did not affect
pancreatic blood flow in rats without administration of
cerulein (Figure 1E). Administration of cerulein for 5 h
significantly reduced pancreatic blood flow by 58% when
compared to that of saline-treated sham-operated control
rats (P<0.001). Exposure to IP significantly reversed the
cerulein-induced fall in pancreatic blood flow (P<0.001),
whereas resveratrol or rofecoxib given alone had no effect
on pancreatic blood flow in animals with cerulein-induced
pancreatitis. Pretreatment with rofecoxib significantly abolished
the IP-induced improvement of pancreatic blood flow in
animals with pancreatitis (P<0.05).
Effect of ischemic preconditioning and cerulein-induced
pancreatitis on synthesis of HSP 70 detected by Western blot
Figure 2 shows the effect of IP and cerulein-induced
pancreatitis on the production of HSP 70 in the pancreatic
tissue. In sham-operated control animals with an intact
pancreas, the synthesis of HSP 70 was weak and the ratio
of HSP 70 over β-actin reached a value of 0.11±0.01. IP
or induction of acute pancreatitis by cerulein significantly
increased the ratio of HSP 70 over β-actin in pancreatic
tissue reaching 0.31±0.01 and 0.74±0.02, respectively
(P<0.05 and P<0.001, respectively). The highest ratio of
HSP 70 to β-actin in pancreatic tissue was observed in
animals treated with combination of IP plus cerulein.
Figure 2  Representative Western blot analysis of β-actin protein (A) and HSP
70 (B), and the ratio of HSP 70 over β-actin protein (C) in pancreatic tissue of
sham-operated control rats (lane 1), rats exposed to IP (lane 2), sham-operated
rats with cerulein-induced pancreatitis (CIP, lane 3), and rats with IP applied
prior to cerulein-induced pancreatitis (IP+CIP, lane 4). bP<0.001 vs sham-operated
rats treated with cerulein alone (CIP), aP<0.05 vs sham-operated saline-treated
control, dP<0.001 vs rats exposed to IP without induction of acute pancreatitis
(CIP).
DISCUSSION
Our present study showed for the first time that: (1) IP could
reduce the pancreatic damage in cerulein-induced acute
pancreatitis; (2) IP and cerulein-induced pancreatitis could
increase synthesis of HSP 70 in the pancreas and combination
of these two factors could stimulate the production of HSP
70 to the highest extent; (3) inhibition of  COXs, especially
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Protective effect of IP against pancreatic damage
evoked by cerulein was manifested by improvement of the
biochemical and histological parameters. Exposure to IP
prior to induction of acute pancreatitis significantly reduced
the cerulein-evoked increase in serum lipase and poly-C
ribonuclease activity, and serum concentration of pro-
inflammatory IL-1β. A close relationship was found between
the IP-evoked decrease in biochemical signs of pancreatitis
and the improvement of pancreatic DNA synthesis, and
pancreatic blood flow, as well as the reduction in histological
score of pancreatic damage. Morphological features showed
a decrease in pancreatic edema, vacuolization of acinar cells,
and leukocyte infiltration of pancreatic tissue.
The increase in serum lipase activity is a well known
manifestation of acute pancreatitis with high sensitivity and
specificity[24]. Pancreatic-type poly-C specific ribonuclease
is one of the few direct markers of severe pancreatic injury
and pancreatic necrosis[21,25]. In our present study, acute
pancreatitis was evoked by stimulation of pancreatitis by
overdose of cerulein. This procedure leads to the development
of mild edematous acute pancreatitis without pancreatic
necrosis[26,27]. However, also in this case, we observed increase
in serum activity of  poly-C specific ribonuclease, suggesting
that serum activity of pancreatic-type poly-C ribonuclease
is not specific for severe pancreatic injury and pancreatic
necrosis, and that serum activity of this enzyme increases
in all types of acute pancreatitis, whereas severity of acute
pancreatitis affects only the degree of poly-C ribonuclease
activity in the serum. This discrepancy between our data
and reports of  Warshaw and Lee[21] or Naskalski et al.[25],
may also be a result of species differences. On the other
hand, our finding that IP applied before induction of acute
pancreatitis reduced serum poly-C ribonuclease activity
provides an additional support for the protective effect of
IP on the pancreas in cerulein-induced pancreatitis.
In our present study, IP applied alone did not significantly
affect pancreatic DNA synthesis. Induction of acute
pancreatitis by cerulein caused a reduction in the pancreatic
DNA synthesis, which is in agreement with previous
observations[28,29] and may be considered as an index of
pancreatic damage. In rats with induction of pancreatitis,
IP attenuated the pancreatitis-evoked fall in pancreatic DNA
synthesis. This observation brings the additional support
for the concept that IP enhances resistance of the pancreas
against tissue damage.
Our present observation that IP reduced pancreatic
damage in cerulein-induced pancreatitis confirms and
extends our previous finding that exposure to IP could
protect the pancreas against damage evoked by severe
ischemia followed by reperfusion[7]. These data suggest that
IP, causing a mild damage, enhances resistance against
pancreatic damage independently to the etiology of  acute
pancreatitis. This hypothesis is also supported by the observation
that exposure to other mild damaging factors such as
bacterial lipopolysaccharides[30], grapefruit-seed extract[22], or
low doses of capsaicin[31] exhibits protective effect against
acute pancreatitis.
The role of  COX-2 in acute pancreatitis is unclear.
Previous experimental studies on mice[13,14] have shown that
pharmacological inhibition of  COX-2 or COX-2 gene
disruption ameliorates the severity of pancreatitis and the
pancreatitis-associated lung injury. In contrast, in the rat
model of  pancreatitis, Foitzik et al.[32], have found some
beneficial systemic effects of  COX-2 inhibition on acute
pancreatitis, such as an improvement of renal and respiratory
function, but they have not observed any significant effect
of  COX-2 inhibition on histological score of  pancreatic
damage or plasma level of trypsinogen activation peptides. In
our present study, blockade of  COX-1 or COX-2 significantly
reduced serum lipase and serum poly-C ribonuclease activity,
as well as decreased pancreatic edema and inflammatory
infiltration in morphological features in animals with cerulein-
induced pancreatitis. The new and important finding of the
present study is that inhibition of  COXs, especially COX-2,
reduces the protective effect of IP against pancreatic damage
evoked by cerulein. This observation indicates that activity
of  COX-2 is necessary for the beneficial effect of  IP. The
involvement of  COX-2 in IP effects on the pancreas is
similar to that observed after treatment with HGF. Serum
concentration of HGF is increased in patients with acute
pancreatitis, and the HGF level reflects the clinical severity
of pancreatitis and organ dysfunction[33,34]. Also experimental
studies have shown the increase in plasma HGF level and
tissue HGF overexpression in acute pancreatitis[35,36]. On
the other hand, administration of antibodies that neutralize
HGF aggravates the organ dysfunction and increases
apoptosis in the course of acute pancreatitis[35], whereas
treatment with HGF reduces pancreatic damage in cerulein-
induced pancreatitis[37]. These data indicate that HGF is not
a pro-inflammatory factor, but a result of pancreatic damage
in acute pancreatitis and the elevation of HGF level plays a
role of self-defense mechanism, limiting the intensity of
inflammatory process. It was reported that inhibition of
COX-2 abolishes the protective effect of  HGF against acute
pancreatitis[15]. Our present study showed that inhibition of
COXs, especially COX-2, reduced the protective effect of
IP against damage evoked by cerulein. These findings taken
together suggest that pancreatoprotective effects evoked
by IP and HGF involve similar but not strictly the same
mechanisms. In contrast to the administration of HGF[37],
exposure to IP did not increase the serum level of anti-
inflammatory IL-10.
Another finding of  our present study is the observation
that cerulein-induced pancreatitis and IP increased pancreatic
synthesis of HSP 70 and these two factors applied together
caused maximal induction of HSP 70 synthesis in the
pancreas. HSPs are highly conserved cytoprotective proteins
that are induced by a variety of stresses including hyper-
and hypothermia, toxin, heavy metals, and free radicals[16].
Previous studies demonstrated that both thermal and non-
thermal stresses protect against cerulein-induced pancreatitis
and prevent trypsinogen activation in the pancreas and this
effect is mediated by HSP 70[38]. HSPs have also been shown
to provide the protection against arginine-[19] and taurocholate-
induced[39] pancreatitis. The potential protective mechanisms
of HSPs on pancreas include stabilization and refolding
of damaged proteins, resistance of cells to apoptosis or
necrosis, decrease in the level of pro-inflammatory cytokines,
antioxidant effects and interference with intra-acinar zymogen
activation[16,38,40]. Our present results are consistent with the
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previous studies showing an increase of HSP 70 at the
mRNA and protein level after induction of cerulein-induced
pancreatitis[41]. The major finding is, however, the observation
of the further increase in HSP 70 synthesis in rats with IP,
which indicates that the protective effects of IP could be
mediated via this HSP.
In conclusion, exposure to IP reduces pancreatic damage
in cerulein-induced acute pancreatitis and this protective
effect of  IP, at least in part, depends on COXs activity and
production of HSP 70.
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